Jundishapur Journal of Microbiology

Published by: Kowsar

Clostridium difficile Infection Among Hospitalized Chronic Hepatitis B Virus-Infected Patients in a Chinese Hospital

Yunbo Chen 1 , Qiaodi Gui 2 , Qiaomai Xu 1 , Tao Lv 1 , Silan Gu 1 , Ping Shen 1 , Jiazheng Quan 1 , Yunhui Fang 1 , Guangyong Ye 3 and Lanjuan Li 4 , *
Authors Information
1 State Key Lab for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
2 Department of Clinical Laboratory, Shaanxi Provincial People’s Hospital, Xi'an, China
3 Department of Clinical Laboratory, Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, China
4 State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
Article information
  • Jundishapur Journal of Microbiology: September 2018, 11 (9); e68809
  • Published Online: September 1, 2018
  • Article Type: Research Article
  • Received: March 19, 2018
  • Revised: July 31, 2018
  • Accepted: August 1, 2018
  • DOI: 10.5812/jjm.68809

To Cite: Chen Y, Gui Q, Xu Q, Lv T, Gu S, et al. Clostridium difficile Infection Among Hospitalized Chronic Hepatitis B Virus-Infected Patients in a Chinese Hospital, Jundishapur J Microbiol. 2018 ; 11(9):e68809. doi: 10.5812/jjm.68809.

Abstract
Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Footnotes
References
  • 1. Bartlett JG, Moon N, Chang TW, Taylor N, Onderdonk AB. Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis. Gastroenterology. 1978;75(5):778-82. [PubMed: 700321].
  • 2. Warny M, Pepin J, Fang A, Killgore G, Thompson A, Brazier J, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet. 2005;366(9491):1079-84. doi: 10.1016/S0140-6736(05)67420-X. [PubMed: 16182895].
  • 3. Leffler DA, Lamont JT. Clostridium difficile infection. N Engl J Med. 2015 Apr 16;372(16):1539-48. doi: 10.1056/NEJMra1403772.
  • 4. Zimlichman E, Henderson D, Tamir O, Franz C, Song P, Yamin CK, et al. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med. 2013;173(22):2039-46. doi: 10.1001/jamainternmed.2013.9763. [PubMed: 23999949].
  • 5. Trifan A, Stoica O, Stanciu C, Cojocariu C, Singeap AM, Girleanu I, et al. Clostridium difficile infection in patients with liver disease: a review. Eur J Clin Microbiol Infect Dis. 2015;34(12):2313-24. doi: 10.1007/s10096-015-2501-z. [PubMed: 26440041].
  • 6. Vanjak D, Girault G, Branger C, Rufat P, Valla DC, Fantin B. Risk factors for Clostridium difficile infection in a hepatology ward. Infect Control Hosp Epidemiol. 2007;28(2):202-4. doi: 10.1086/511790. [PubMed: 17265403].
  • 7. Ali M, Ananthakrishnan AN, Ahmad S, Kumar N, Kumar G, Saeian K. Clostridium difficile infection in hospitalized liver transplant patients: a nationwide analysis. Liver Transpl. 2012;18(8):972-8. doi: 10.1002/lt.23449. [PubMed: 22505356]. [PubMed Central: PMC3405162].
  • 8. Mittal C, Hassan S, Arshad S, Jeepalyam S, Bruni S, Miceli M, et al. Clostridium difficile infection in liver transplant recipients: a retrospective study of rates, risk factors and outcomes. Am J Transplant. 2014;14(8):1901-7. doi: 10.1111/ajt.12798. [PubMed: 24902610].
  • 9. Lu H, Wu Z, Xu W, Yang J, Chen Y, Li L. Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection. Intestinal microbiota of HBV cirrhotic patients. Microb Ecol. 2011;61(3):693-703. doi: 10.1007/s00248-010-9801-8. [PubMed: 21286703].
  • 10. Steele SR, McCormick J, Melton GB, Paquette I, Rivadeneira DE, Stewart D, et al. Practice parameters for the management of Clostridium difficile infection. Dis Colon Rectum. 2015;58(1):10-24. doi: 10.1097/DCR.0000000000000289. [PubMed: 25489690].
  • 11. Kato H, Kato N, Watanabe K, Iwai N, Nakamura H, Yamamoto T, et al. Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR. J Clin Microbiol. 1998;36(8):2178-82. [PubMed: 9665986]. [PubMed Central: PMC105000].
  • 12. Stubbs S, Rupnik M, Gibert M, Brazier J, Duerden B, Popoff M. Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile. FEMS Microbiol Lett. 2000;186(2):307-12. doi: 10.1111/j.1574-6968.2000.tb09122.x. [PubMed: 10802189].
  • 13. Griffiths D, Fawley W, Kachrimanidou M, Bowden R, Crook DW, Fung R, et al. Multilocus sequence typing of Clostridium difficile. J Clin Microbiol. 2010;48(3):770-8. doi: 10.1128/JCM.01796-09. [PubMed: 20042623]. [PubMed Central: PMC2832416].
  • 14. Hensgens MP, Goorhuis A, Dekkers OM, van Benthem BH, Kuijper EJ. All-cause and disease-specific mortality in hospitalized patients with Clostridium difficile infection: a multicenter cohort study. Clin Infect Dis. 2013;56(8):1108-16. doi: 10.1093/cid/cis1209. [PubMed: 23300235].
  • 15. Bauer MP, Notermans DW, van Benthem BH, Brazier JS, Wilcox MH, Rupnik M, et al. Clostridium difficile infection in Europe: A hospital-based survey. Lancet. 2011;377(9759):63-73. doi: 10.1016/S0140-6736(10)61266-4. [PubMed: 21084111].
  • 16. Redelings MD, Sorvillo F, Mascola L. Increase in Clostridium difficile-related mortality rates, United States, 1999-2004. Emerg Infect Dis. 2007;13(9):1417-9. doi: 10.3201/eid1309.061116. [PubMed: 18252127]. [PubMed Central: PMC2857309].
  • 17. Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2014;370(13):1198-208. doi: 10.1056/NEJMoa1306801. [PubMed: 24670166]. [PubMed Central: PMC4648343].
  • 18. Beckebaum S, Malago M, Dirsch O, Cicinnati VR, Trippler M, Lampertico P, et al. Efficacy of combined lamivudine and adefovir dipivoxil treatment for severe HBV graft reinfection after living donor liver transplantation. Clin Transplant. 2003;17(6):554-9. doi: 10.1046/j.0902-0063.2003.00097.x. [PubMed: 14756274].
  • 19. Castelnau C, Le Gal F, Ripault MP, Gordien E, Martinot-Peignoux M, Boyer N, et al. Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up. Hepatology. 2006;44(3):728-35. doi: 10.1002/hep.21325. [PubMed: 16941695].
  • 20. Vonberg RP, Kuijper EJ, Wilcox MH, Barbut F, Tull P, Gastmeier P, et al. Infection control measures to limit the spread of Clostridium difficile. Clin Microbiol Infect. 2008;14 Suppl 5:2-20. doi: 10.1111/j.1469-0691.2008.01992.x. [PubMed: 18412710].
  • 21. Chen YB, Gu SL, Shen P, Lv T, Fang YH, Tang LL, et al. Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from hospitals during a 4-year period in China. J Med Microbiol. 2018;67(1):52-9. doi: 10.1099/jmm.0.000646. [PubMed: 29160203].
  • 22. Xu Q, Chen Y, Gu S, Lv T, Zheng B, Shen P, et al. Hospital-acquired Clostridium difficile infection in Mainland China: A seven-year (2009-2016) retrospective study in a large university hospital. Sci Rep. 2017;7(1):9645. doi: 10.1038/s41598-017-09961-0. [PubMed: 28852010]. [PubMed Central: PMC5575102].
  • 23. Abou Chakra CN, Pepin J, Sirard S, Valiquette L. Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review. PLoS One. 2014;9(6). e98400. doi: 10.1371/journal.pone.0098400. [PubMed: 24897375]. [PubMed Central: PMC4045753].
  • 24. Tang C, Cui L, Xu Y, Xie L, Sun P, Liu C, et al. The incidence and drug resistance of Clostridium difficile infection in Mainland China: a systematic review and meta-analysis. Sci Rep. 2016;6:37865. doi: 10.1038/srep37865. [PubMed: 27897206]. [PubMed Central: PMC5126672].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments